BioLineRx Announces Publication of Results from Previous Phase 1/2 Trial o f BL-1040; Expecting Study Completion Mid '15
October 31, 2014 at 07:08 AM EDT
BioLineRx Ltd. (NASDAQ: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing ...